{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:44:15Z","timestamp":1793119455220,"version":"4.5.0"},"reference-count":64,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,11,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a potentially fatal blood disorder resulting from acquired deficiency of plasma ADAMTS13 activity. Despite recent advances in early diagnosis and novel therapeutics, the mortality rate of acute iTTP remains as high as 10% to 20%. Moreover, a reliable clinical and laboratory parameter that predicts disease severity and outcomes is lacking. We show in the present study that plasma levels of syndecan-1 (Sdc-1) and soluble thrombomodulin (sTM) on admission were dramatically increased in patients with acute iTTP and remained substantially elevated in a subset of patients compared with healthy controls. The elevated admission plasma levels of Sdc-1 and sTM were associated with abnormal Glasgow coma scale scores, low estimated glomerular filtration rates, the need for intensive care, and in-hospital mortality rates. Moreover, a further simultaneous increase in plasma Sdc-1 and sTM levels at the time of clinical response\/remission (eg, when normalization of platelet counts and substantial reduction of serum lactate dehydrogenase activity were achieved) was highly predictive of iTTP recurrence. These results demonstrate that endothelial injury, resulting from disseminated microvascular thromboses, is severe and persistent in patients with acute iTTP. Plasma levels of Sdc-1 and sTM on admission and in remission are predictive of in-hospital mortality and recurrence of acute iTTP, respectively. Thus, an incorporation of such novel plasma biomarkers into the risk assessment in acute iTTP may help implement a more vigorous and intensive therapeutic strategy for these patients.<\/jats:p>","DOI":"10.1182\/bloodadvances.2020003065","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T17:07:23Z","timestamp":1604423243000},"page":"5378-5388","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":20,"title":["Elevated plasma levels of syndecan-1 and soluble thrombomodulin predict adverse outcomes in thrombotic thrombocytopenic purpura"],"prefix":"10.1182","volume":"4","author":[{"given":"Ruinan","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS; and"},{"name":"Department of Pathology, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingrui","family":"Sui","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1680-5295","authenticated-orcid":false,"given":"X. Long","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS; and"},{"name":"Department of Pathology, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,11,3]]},"reference":[{"issue":"7","key":"2020110311373659400_B1","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1538-7836.2005.01436.x","article-title":"The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency","volume":"3","author":"Terrell","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2020110311373659400_B2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3324\/haematol.2018.198275","article-title":"Clinical factors and biomarkers predict outcome in patients with immune-mediated thrombotic thrombocytopenic purpura","volume":"104","author":"Staley","year":"2019","journal-title":"Haematologica"},{"issue":"22","key":"2020110311373659400_B3","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"issue":"9","key":"2020110311373659400_B4","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.019299","article-title":"Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura","volume":"95","author":"Zheng","year":"2010","journal-title":"Haematologica"},{"issue":"2","key":"2020110311373659400_B5","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/jth.13571","article-title":"Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies","volume":"15","author":"Scully","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"10","key":"2020110311373659400_B6","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1111\/jth.13764","article-title":"Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics","volume":"15","author":"Saha","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"6855","key":"2020110311373659400_B7","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"issue":"6","key":"2020110311373659400_B8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1056\/NEJM199108083250605","article-title":"Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients","volume":"325","author":"Bell","year":"1991","journal-title":"N Engl J Med"},{"issue":"6","key":"2020110311373659400_B9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med"},{"issue":"11","key":"2020110311373659400_B10","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1182\/blood-2003-11-4035","article-title":"Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura","volume":"103","author":"Zheng","year":"2004","journal-title":"Blood"},{"key":"2020110311373659400_B11","article-title":"ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura","author":"Zheng","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2020110311373659400_B12","first-page":"336","article-title":"Minor stroke as singular manifestation of hereditary thrombotic thrombocytopenic purpura in a young man","volume":"28","author":"Lindblom","year":"2009","journal-title":"Int Angiol"},{"issue":"9","key":"2020110311373659400_B13","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1136\/emj.2006.036327","article-title":"Thrombotic thrombocytopenic purpura mimicking acute ischemic stroke","volume":"23","author":"Aksay","year":"2006","journal-title":"Emerg Med J"},{"issue":"5","key":"2020110311373659400_B14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jca.21510","article-title":"Increased troponin I is associated with fatal outcome in acquired thrombotic thrombocytopenic purpura","volume":"32","author":"Brazelton","year":"2017","journal-title":"J Clin Apher"},{"issue":"20","key":"2020110311373659400_B15","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1182\/blood-2010-07-271445","article-title":"How I treat patients with thrombotic thrombocytopenic purpura: 2010","volume":"116","author":"George","year":"2010","journal-title":"Blood"},{"issue":"1","key":"2020110311373659400_B16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/rth2.12160","article-title":"Thrombotic thrombocytopenic purpura: toward targeted therapy and precision medicine","volume":"3","author":"Coppo","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"issue":"10","key":"2020110311373659400_B17","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1111\/jth.15009","article-title":"Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura","volume":"18","author":"Zheng","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"8","key":"2020110311373659400_B18","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1182\/blood-2009-09-243790","article-title":"Survival and relapse in patients with thrombotic thrombocytopenic purpura","volume":"115","author":"Kremer Hovinga","year":"2010","journal-title":"Blood"},{"key":"2020110311373659400_B19","doi-asserted-by":"crossref","first-page":"1016.e1011","DOI":"10.1016\/j.amjmed.2013.03.021","article-title":"Predictors of in-hospital mortality and acute myocardial infarction in thrombotic thrombocytopenic purpura","volume":"126","author":"Balasubramaniyam","year":"2013","journal-title":"Am J Med"},{"issue":"6","key":"2020110311373659400_B20","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/trf.13586","article-title":"Prognostic risk-stratified score for predicting mortality in hospitalized patients with thrombotic thrombocytopenic purpura: nationally representative data from 2007 to 2012","volume":"56","author":"Goel","year":"2016","journal-title":"Transfusion"},{"issue":"8","key":"2020110311373659400_B21","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3324\/haematol.2011.049676","article-title":"Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience","volume":"97","author":"Benhamou","year":"2012","journal-title":"Haematologica"},{"issue":"2","key":"2020110311373659400_B22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/jth.12790","article-title":"Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura","volume":"13","author":"Benhamou","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2020110311373659400_B23","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1182\/blood-2016-12-758656","article-title":"Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpura","volume":"130","author":"Alwan","year":"2017","journal-title":"Blood"},{"issue":"10","key":"2020110311373659400_B24","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3324\/haematol.2011.042945","article-title":"ADAMTS13 activity and antigen during therapy and follow-up of patients with idiopathic thrombotic thrombocytopenic purpura: correlation with clinical outcome","volume":"96","author":"Yang","year":"2011","journal-title":"Haematologica"},{"issue":"15","key":"2020110311373659400_B25","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1111\/febs.14828","article-title":"Structures and interactions of syndecans","volume":"286","author":"Gondelaud","year":"2019","journal-title":"FEBS J"},{"issue":"31","key":"2020110311373659400_B26","doi-asserted-by":"crossref","first-page":"18759","DOI":"10.1074\/jbc.271.31.18759","article-title":"Suppression of syndecan-1 expression in endothelial cells by tumor necrosis factor-alpha","volume":"271","author":"Kainulainen","year":"1996","journal-title":"J Biol Chem"},{"issue":"1","key":"2020110311373659400_B27","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1055\/s-0038-1657558","article-title":"Thrombomodulin structure and function","volume":"78","author":"Sadler","year":"1997","journal-title":"Thromb Haemost"},{"issue":"5","key":"2020110311373659400_B28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s004240000307","article-title":"The endothelial surface layer","volume":"440","author":"Pries","year":"2000","journal-title":"Pflugers Arch"},{"issue":"6777","key":"2020110311373659400_B29","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/35006683","article-title":"Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex","volume":"404","author":"Fuentes-Prior","year":"2000","journal-title":"Nature"},{"issue":"1","key":"2020110311373659400_B30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00281-011-0282-8","article-title":"Thrombomodulin and its role in inflammation","volume":"34","author":"Conway","year":"2012","journal-title":"Semin Immunopathol"},{"issue":"7","key":"2020110311373659400_B31","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/j.1460-2075.1987.tb02448.x","article-title":"Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation","volume":"6","author":"Suzuki","year":"1987","journal-title":"EMBO J"},{"issue":"4","key":"2020110311373659400_B32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","article-title":"Thrombomodulin mutations in atypical hemolytic-uremic syndrome","volume":"361","author":"Delvaeye","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"2020110311373659400_B33","doi-asserted-by":"crossref","first-page":"H1672","DOI":"10.1152\/ajpheart.00832.2003","article-title":"Inflammation- and ischemia-induced shedding of venular glycocalyx","volume":"286","author":"Mulivor","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"2020110311373659400_B34","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1074\/jbc.M109.059394","article-title":"A disintegrin and metalloproteinase 17 (ADAM17) mediates inflammation-induced shedding of syndecan-1 and -4 by lung epithelial cells","volume":"285","author":"Pruessmeyer","year":"2010","journal-title":"J Biol Chem"},{"key":"2020110311373659400_B35","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1152\/japplphysiol.00436.2005","article-title":"Short-term hyperglycemia increases endothelial glycocalyx permeability and acutely decreases lineal density of capillaries with flowing red blood cells","volume":"99","author":"Zuurbier","year":"2005","journal-title":"J Appl Physiol."},{"issue":"5","key":"2020110311373659400_B36","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/TA.0000000000001993","article-title":"Acute hyperglycemia exacerbates trauma-induced endothelial and glycocalyx injury: an in vitro model","volume":"85","author":"Diebel","year":"2018","journal-title":"J Trauma Acute Care Surg"},{"issue":"14","key":"2020110311373659400_B37","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1182\/blood-2009-02-204966","article-title":"Syndecan-1 shedding facilitates the resolution of neutrophilic inflammation by removing sequestered CXC chemokines","volume":"114","author":"Hayashida","year":"2009","journal-title":"Blood"},{"issue":"1","key":"2020110311373659400_B38","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13049-018-0565-3","article-title":"Traumatic brain injury is associated with increased syndecan-1 shedding in severely injured patients","volume":"26","author":"Gonzalez Rodriguez","year":"2018","journal-title":"Scand J Trauma Resusc Emerg Med"},{"issue":"3","key":"2020110311373659400_B39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/0267659108098215","article-title":"Syndecan-1 plasma levels during coronary artery bypass surgery with and without cardiopulmonary bypass","volume":"23","author":"Svennevig","year":"2008","journal-title":"Perfusion"},{"key":"2020110311373659400_B43","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.2147\/COPD.S207855","article-title":"Circulating syndecan-1 as a novel biomarker relates to lung function, systemic inflammation, and exacerbation in COPD","volume":"14","author":"Li","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"5-6","key":"2020110311373659400_B40","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.cyto.2006.05.008","article-title":"Synergistic effect of tumor necrosis factor-alpha and interferon-gamma on enterocyte shedding of syndecan-1 and associated decreases in internalization of Listeria monocytogenes and Staphylococcus aureus","volume":"34","author":"Henry-Stanley","year":"2006","journal-title":"Cytokine"},{"issue":"1","key":"2020110311373659400_B41","first-page":"134","article-title":"Release of thrombomodulin from endothelial cells by concerted action of TNF-alpha and neutrophils: in vivo and in vitro studies","volume":"87","author":"Boehme","year":"1996","journal-title":"Immunology"},{"issue":"3","key":"2020110311373659400_B42","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00395-013-0347-z","article-title":"Physiological levels of A-, B- and C-type natriuretic peptide shed the endothelial glycocalyx and enhance vascular permeability","volume":"108","author":"Jacob","year":"2013","journal-title":"Basic Res Cardiol"},{"key":"2020110311373659400_B44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jcrc.2018.06.015","article-title":"Glycocalyx biomarker syndecan-1 is a stronger predictor of respiratory failure in patients with sepsis due to pneumonia, compared to endocan","volume":"47","author":"Smart","year":"2018","journal-title":"J Crit Care"},{"issue":"6","key":"2020110311373659400_B45","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1097\/TA.0000000000000631","article-title":"Syndecan-1 restitution by plasma after hemorrhagic shock","volume":"78","author":"Kozar","year":"2015","journal-title":"J Trauma Acute Care Surg"},{"key":"2020110311373659400_B46","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jcrc.2017.07.049","article-title":"Circulating syndecan-1 predicts the development of disseminated intravascular coagulation in patients with sepsis","volume":"43","author":"Ikeda","year":"2018","journal-title":"J Crit Care"},{"key":"2020110311373659400_B47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jcrc.2016.06.027","article-title":"Plasma syndecan-1 levels identify a cohort of patients with severe sepsis at high risk for intubation after large-volume intravenous fluid resuscitation","volume":"36","author":"Puskarich","year":"2016","journal-title":"J Crit Care"},{"issue":"10","key":"2020110311373659400_B48","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1182\/blood.V76.10.2024.2024","article-title":"Plasma thrombomodulin in health and diseases","volume":"76","author":"Takano","year":"1990","journal-title":"Blood"},{"issue":"4","key":"2020110311373659400_B49","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/00005373-199510000-00007","article-title":"Soluble thrombomodulin increases in patients with disseminated intravascular coagulation and in those with multiple organ dysfunction syndrome after trauma: role of neutrophil elastase","volume":"39","author":"Gando","year":"1995","journal-title":"J Trauma"},{"issue":"5","key":"2020110311373659400_B50","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/00005373-199805000-00008","article-title":"Endothelial cell injury, as quantified by the soluble thrombomodulin level, predicts sepsis\/multiple organ dysfunction syndrome after blunt trauma","volume":"44","author":"Ikegami","year":"1998","journal-title":"J Trauma"},{"issue":"3","key":"2020110311373659400_B51","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/CCM.0B013E31816537D8","article-title":"Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis","volume":"36","author":"Lin","year":"2008","journal-title":"Crit Care Med"},{"issue":"7872","key":"2020110311373659400_B52","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0140-6736(74)91639-0","article-title":"Assessment of coma and impaired consciousness. A practical scale","volume":"2","author":"Teasdale","year":"1974","journal-title":"Lancet"},{"issue":"2","key":"2020110311373659400_B53","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ab.2006.06.022","article-title":"Creation of a recombinant peptide substrate for fluorescence resonance energy transfer-based protease assays","volume":"358","author":"Zhang","year":"2006","journal-title":"Anal Biochem"},{"issue":"8","key":"2020110311373659400_B54","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood-2009-01-195461","article-title":"Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site","volume":"114","author":"Raife","year":"2009","journal-title":"Blood"},{"key":"2020110311373659400_B55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mvr.2013.02.001","article-title":"The endothelial glycocalyx in syndecan-1 deficient mice","volume":"87","author":"Savery","year":"2013","journal-title":"Microvasc Res"},{"issue":"24","key":"2020110311373659400_B56","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1182\/bloodadvances.2019000939","article-title":"Longitudinal assessments of plasma ADAMTS13 biomarkers predict recurrence of immune thrombotic thrombocytopenic purpura","volume":"3","author":"Sui","year":"2019","journal-title":"Blood Adv"},{"issue":"5","key":"2020110311373659400_B57","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0092-8674(02)01079-6","article-title":"Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury","volume":"111","author":"Li","year":"2002","journal-title":"Cell"},{"issue":"21","key":"2020110311373659400_B58","doi-asserted-by":"crossref","first-page":"10542","DOI":"10.1073\/pnas.89.21.10542","article-title":"High- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils","volume":"89","author":"Schumacher","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2020110311373659400_B59","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1165\/rcmb.2015-0193OC","article-title":"Shedding of syndecan-1\/CXCL1 complexes by matrix metalloproteinase 7 functions as an epithelial checkpoint of neutrophil activation","volume":"55","author":"Gill","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"2020110311373659400_B60","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1084\/jem.20020077","article-title":"The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways","volume":"196","author":"Conway","year":"2002","journal-title":"J Exp Med"},{"issue":"8","key":"2020110311373659400_B61","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/j.1538-7836.2006.02033.x","article-title":"The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis","volume":"4","author":"Van de Wouwer","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2020110311373659400_B62","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1517\/14728222.2016.1086750","article-title":"Thrombomodulin as an intravascular safeguard against inflammatory and thrombotic diseases","volume":"20","author":"Ito","year":"2016","journal-title":"Expert Opin Ther Targets"},{"issue":"9","key":"2020110311373659400_B63","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1182\/blood-2008-03-142760","article-title":"Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response","volume":"112","author":"Shi","year":"2008","journal-title":"Blood"},{"issue":"7","key":"2020110311373659400_B64","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1097\/TP.0000000000002170","article-title":"Syndecan-1 shedding inhibition to protect against ischemic acute kidney injury through HGF target signaling pathway","volume":"102","author":"Lu","year":"2018","journal-title":"Transplantation"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/21\/5378\/1780310\/advancesadv2020003065.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/21\/5378\/1780310\/advancesadv2020003065.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T17:08:06Z","timestamp":1604423286000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/21\/5378\/469824\/Elevated-plasma-levels-of-syndecan1-and-soluble"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,3]]},"references-count":64,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2020,11,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2020003065","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,3]]}}}